What laboratory tests are recommended for the evaluation of hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Tests for Hypertension Evaluation

The essential laboratory tests for hypertension evaluation include blood tests for sodium, potassium, serum creatinine with eGFR, lipid profile, fasting glucose, complete blood count, thyroid-stimulating hormone, urinalysis, and a 12-lead ECG. 1

Basic Laboratory Tests (Required for All Hypertensive Patients)

Blood Tests

  • Sodium and potassium: To identify electrolyte abnormalities that may suggest secondary causes of hypertension 1
  • Serum creatinine with estimated glomerular filtration rate (eGFR): To assess kidney function and establish baseline renal status 1
  • Lipid profile: To evaluate cardiovascular risk and guide management decisions 1
  • Fasting blood glucose: To screen for diabetes or prediabetes, which frequently coexists with hypertension (present in 15-20% of hypertensive patients) 1, 2
  • Complete blood count: To evaluate for anemia or other hematologic abnormalities 1, 2
  • Thyroid-stimulating hormone: To screen for thyroid dysfunction as a potential secondary cause 1, 2

Urine Tests

  • Urinalysis: To screen for kidney disease and detect hematuria 1
  • Urinary albumin-to-creatinine ratio: More sensitive than dipstick urinalysis for detecting early kidney damage (recommended over urine dipstick) 1, 2

Cardiac Assessment

  • 12-lead ECG: To detect atrial fibrillation, left ventricular hypertrophy, or ischemic heart disease 1

Optional Tests (Based on Clinical Indications)

Cardiovascular Assessment

  • Echocardiography: For patients with uncontrolled hypertension, suspected hypertensive heart disease, or abnormal ECG findings 1
  • Carotid ultrasound: To detect plaques or stenosis indicating atherosclerosis 1
  • Ankle-brachial index: To evaluate for peripheral artery disease 1

Additional Laboratory Tests

  • Serum uric acid: Common in hypertensive patients (25%) and may provide additional risk stratification 1, 2
  • Liver function tests: Particularly in patients with metabolic syndrome or suspected fatty liver disease 1

Tests for Suspected Secondary Hypertension

  • Aldosterone-renin ratio: When primary aldosteronism is suspected (hypokalemia, resistant hypertension) 1
  • Plasma free metanephrines: When pheochromocytoma is suspected (episodic hypertension, palpitations, sweating) 1
  • Late-night salivary cortisol: When Cushing's syndrome is suspected (central obesity, facial rounding, striae) 1

Imaging Studies (When Indicated)

  • Renal ultrasound/Doppler: To evaluate for renal parenchymal disease or renal artery stenosis 1
  • CT/MR angiography: For suspected renal artery stenosis or adrenal pathology 1
  • Brain CT/MRI: When hypertensive brain injury is suspected or in patients with neurological symptoms 1, 3
  • Fundoscopy: To evaluate for retinal changes, hemorrhages, papilledema 1, 3

Clinical Pitfalls to Avoid

  • Relying on urine dipstick alone instead of quantitative urinary albumin-to-creatinine ratio can miss early kidney damage 1, 2
  • Failing to check standing blood pressure to detect orthostatic hypotension, especially in older adults 1, 2
  • Not considering secondary causes of hypertension in patients with resistant hypertension, early-onset hypertension, or severe hypertension 1
  • Overlooking the need for more extensive evaluation in patients with abnormal basic laboratory findings 1, 2

Risk Factor Assessment

  • More than 50% of hypertensive patients have additional cardiovascular risk factors that should be identified and managed 1
  • Common coexisting conditions include diabetes (15-20%), lipid disorders (30%), obesity (40%), hyperuricemia (25%), and metabolic syndrome (40%) 1
  • Identifying these risk factors is crucial for comprehensive cardiovascular risk assessment and management 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Evaluation of Stage 1 Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluation of Blurry Vision in a Hypertensive Patient

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.